Compare Eli Lilly And Co (LLY) vs Nutanix Inc (NTNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Nutanix Inc — how do they compare? Eli Lilly And Co trades at $1,170.93 (market cap $1.02T), while Nutanix Inc trades at $54 (market cap $14.90B). The key difference: Eli Lilly And Co is far larger — about 68.5× Nutanix Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| LLY | NTNX | |
|---|---|---|
Market Cap | $1.02T | $14.90B |
Sector | Health | Technology |
52-Week High | $1.24K | $81.12 |
52-Week Low | $625.65 | $34.41 |
Enterprise Value | $1.06T | $14.41B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →
